Enrolled (n=85) | Not enrolled (n=212) | cOR (95% CI) | p-value | aOR (95% CI) | p-value | |
---|---|---|---|---|---|---|
Gender | ||||||
Female | 52 (61.1%) | 91 (42.9%) | ref | < 0.01 | ref | < 0.01 |
Male | 33 (38.9%) | 121 (57.1%) | 0.49 (0.29-0.82)* | 0.45 (0.26-0.78)* | ||
Age group | ||||||
≤ 30 | 36 (42.4%) | 95 (44.8%) | ref | 0.63 | ||
> 30 | 48 (57.6%) | 116 (55.2%) | 1.14 (0.68-1.89) | |||
Registration group | ||||||
New | 79 (92.9%) | 169 (79.7%) | ref | < 0.01 | ref | < 0.01 |
Previously treated/Others | 6 (7.1%) | 43 (20.3%) | 0.30 (0.12-0.74)* | 0.29 (0.11-0.75)* | ||
Site of disease | ||||||
PTB | 61 (71.7%) | 175 (82.5%) | ref | 0.03 | ||
EPTB | 24 (28.3%) | 37 (17.5%) | 1.90 (1.05-3.44)* | |||
Registration year | ||||||
2009 | 28 (32.9%) | 108 (50.9%) | ref | < 0.01 | ref | < 0.01 |
2010 | 57 (67.1%) | 104 (49.1%) | 2.06 (1.21-3.49)* | 2.80 (1.53-5.12)* | ||
Registration site | ||||||
ARTsites | 84 (98.8%) | 192 (90.6%) | ref | 0.01 | ref | 0.03 |
non-ART sites | 1 (1.2%) | 20 (9.4%) | 0.11 (0.02-0.87)* | 0.10 (0.01-0.77)* | ||
TB treatment outcomes | ||||||
Treatment success | 53 (62.3%) | 107 (50.5%) | ref | ref | ||
Died | 5 (5.9%) | 29 (13.7%) | 0.27 (0.01-0.80)* | 0.02 | 0.20 (0.06-0.65)* | < 0.01 |
Default | 22 (25.9%) | 65 (30.1%) | 0.68 (0.38-1.23) | 0.20 | ||
Transfer out | 5 (5.9%) | 11 (5.7%) | 1.14 (0.30-2.78) | 0.88 |